IDiyas

For the Inventor, By the Inventor

Arlesheim, Switzerland

Peter Buhlmayer

USPTO Granted Patents = 16

Average Co-Inventor Count = 3.4

ph-index = 10

Forward Citations = 389(Granted Patents)


Company Filing History:

goldMedal15 out of 6,850 
 
Ciba-geigy Corporation
 patents
silverMedal1 out of 166 
 
Novartis Corporation
 patents

Years Active: 1986-1999

Loading Chart...
16 patents (USPTO):
1. 5965592 - Acyl compounds (1999-10-12),
2. 5955487 - N-acyl-N-heterocyclylalkyamino acids compositions and method of use (1999-09-21),
3. 5683997 - Substituted benzazepinones (1997-11-04),
4. 5610153 - Benzazepinone derivatives (1997-03-11),
5. 5506240 - N-acyl-n-quinolinyl or isoquinounyl alkylamino acids compositions and (1996-04-09),
6. 5399578 - Acyl compounds (1995-03-21),
7. 5369110 - Biphenylyl compounds (1994-11-29),
8. 4931591 - Novel 5-amino-4-hydroxyvaleryl derivatives (1990-06-05),
9. 4914129 - Antihypertensive 5-amino-4-hydroxyvaleryl derivatives substituted by (1990-04-03),
10. 4889869 - Antihypertensive 5-amino-4-hydroxyvaleryl derivatives substituted by (1989-12-26),
11. 4863903 - Substituted 5-amino-4-hydroxyvaleryl derivatives (1989-09-05),
12. 4758584 - Antihypertensive 5-amino-4-hydroxyvaleryl derivatives substituted by (1988-07-19),
13. 4727060 - Novel 5-amino-4-hydroxyvaleryl derivatives (1988-02-23),
14. 4719288 - Substituted 5-amino-4-hydroxyvaleryl derivatives (1988-01-12),
15. 4613676 - Substituted 5-amino-4-hydroxyvaleryl derivatives (1986-09-23),

Title: The Innovative Journey of Peter Buhlmayer

Introduction

Peter Buhlmayer, an accomplished inventor based in Arlesheim, Switzerland, has made significant contributions to the field of medicinal chemistry with his innovative patents. With a total of 16 patents to his name, Buhlmayer exemplifies the spirit of innovation and dedication to advancing scientific knowledge.

Latest Patents

Among his latest patents is a groundbreaking innovation involving acyl compounds. This patent details compounds of a specific formula where various aliphatic hydrocarbon radicals and functional groups play crucial roles. These compounds are prepared through known methods and are envisioned as active ingredients for medicaments, highlighting their potential therapeutic applications.

Additionally, Buhlmayer has developed a patent related to N-acyl-N-heterocyclylalkylamino acids. This invention outlines a new class of amino acids characterized by their unique formula, with substituents that can include halogens, hydroxyl groups, or various alkyl configurations. The versatility of this compound further reinforces Buhlmayer's impact on the field.

Career Highlights

Throughout his career, Buhlmayer has worked with prominent companies such as Ciba-Geigy Corporation and Novartis Corporation. His work in these leading pharmaceutical companies has contributed to the development of innovative products and therapies, showcasing his expertise and commitment to advancing medical research.

Collaborations

Buhlmayer has collaborated with notable individuals in the scientific community, including Walter Fuhrer and Vittorio Rasetti. These collaborations have not only enhanced his work but have also fostered a culture of innovation and teamwork within the research environment.

Conclusion

Peter Buhlmayer stands out as a remarkable inventor whose work in medicinal chemistry has paved the way for new treatments and therapies. His numerous patents demonstrate his dedication to innovation and furthering scientific discovery. As he continues to push the boundaries of research, Buhlmayer's contributions will undoubtedly have a lasting impact on the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…